1. Home
  2. PFLT vs IMTXW Comparison

PFLT vs IMTXW Comparison

Compare PFLT & IMTXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFLT
  • IMTXW
  • Stock Information
  • Founded
  • PFLT N/A
  • IMTXW N/A
  • Country
  • PFLT United States
  • IMTXW Germany
  • Employees
  • PFLT N/A
  • IMTXW 343
  • Industry
  • PFLT Finance: Consumer Services
  • IMTXW Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PFLT Finance
  • IMTXW Health Care
  • Exchange
  • PFLT Nasdaq
  • IMTXW Nasdaq
  • Market Cap
  • PFLT N/A
  • IMTXW N/A
  • IPO Year
  • PFLT N/A
  • IMTXW N/A
  • Fundamental
  • Price
  • PFLT $11.93
  • IMTXW $3.36
  • Analyst Decision
  • PFLT Buy
  • IMTXW
  • Analyst Count
  • PFLT 1
  • IMTXW 0
  • Target Price
  • PFLT $12.50
  • IMTXW N/A
  • AVG Volume (30 Days)
  • PFLT 680.4K
  • IMTXW N/A
  • Earning Date
  • PFLT 08-07-2024
  • IMTXW N/A
  • Dividend Yield
  • PFLT 10.31%
  • IMTXW N/A
  • EPS Growth
  • PFLT N/A
  • IMTXW N/A
  • EPS
  • PFLT 1.54
  • IMTXW N/A
  • Revenue
  • PFLT $155,774,000.00
  • IMTXW N/A
  • Revenue This Year
  • PFLT $14.65
  • IMTXW N/A
  • Revenue Next Year
  • PFLT $23.17
  • IMTXW N/A
  • P/E Ratio
  • PFLT $7.75
  • IMTXW N/A
  • Revenue Growth
  • PFLT 29.37
  • IMTXW N/A
  • 52 Week Low
  • PFLT $9.69
  • IMTXW N/A
  • 52 Week High
  • PFLT $12.63
  • IMTXW N/A
  • Technical
  • Relative Strength Index (RSI)
  • PFLT 69.72
  • IMTXW N/A
  • Support Level
  • PFLT $11.75
  • IMTXW N/A
  • Resistance Level
  • PFLT $11.97
  • IMTXW N/A
  • Average True Range (ATR)
  • PFLT 0.13
  • IMTXW 0.00
  • MACD
  • PFLT 0.05
  • IMTXW 0.00
  • Stochastic Oscillator
  • PFLT 86.15
  • IMTXW 0.00

About IMTXW Immatics N.V.

Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.

Share on Social Networks: